chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A report was received from a health care professional on 11/14/03 concerning a female vaccinee in her 40s who experienced muscle soreness around the injection site, limitation of motion, and muscle weakness within one week of receiving Fluvirin on 10/14/03. Within one week of receiving Fluvirin, the vaccinee experienced muscle soreness around the injection site, limitation of motion, and muscle weakness. The vaccinee had not recovered at the time of the report. The vaccinee had no previous medical history. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 019B21A and 014M20A) for COVID-19 vaccination. No Medical History information was reported. On 27-Feb-2021 at 11:27 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 27-Mar-2021 at 11:07 AM, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. In 2021, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Age of patient was reported as 62.20 for dose administered on 27-Feb-2021 and 62.28 for dose administered on 27-Mar-2021. Concomitant product use was not provided by the reporter. Batch number 014M20A underwent temperature excursion on 27-Feb-2021 with temperature 33, 34 and 35 degrees Fahrenheit from 09:00 AM to 05:00 PM. This vial was moved to fridge on 24-Feb-2021 and beyond use date for the vial was reported as 26-Mar-2021. Product moved to clinic on 27-Feb-2021. Batch number 019B21A underwent temperature excursion on 27-Mar-2021 with temperature 35 degrees Fahrenheit from 09:00 AM to 10:00 AM. This vial was moved to fridge on 23-Mar-2021 and beyond use date for the vial was reported as 22-Apr-2021. Product moved to clinic on 27-Mar-2021. Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a Fisherbrand traceable temperature monitor at every hour. Treatment information was not provided. This case was linked to MOD-2022-566976 (Patient Link).
Redness; itching; warm to touch at injection site. About the size of a dollar; This is a spontaneous report from a contactable Nurse. A 93-year-old non pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EN9581), via intramuscular route of administration on 19Feb2021 as SINGLE DOSE in Arm Left for covid-19 immunization. Medical history included HTN, atrial fib, renal cell carcinoma, arthritis, osteopenia. The patient received first dose of BNT162B2 (Lot number: EL9264) via intramuscular route of administration on 29Jan2021 as SINGLE DOSE (at the age of 93-years) in Arm Left for covid-19 immunization. The patient had known allergies to: Ace inhibitors, valsartan, penicillins, azithromycin. The patient did not receive any other vaccine in four weeks. The concomitant medications included: warfarin, latanoprost, phosphatidyl, selenium, triamcinolone acetonide (Kenalog [triamcinolone acetonide]) ointment, curcuma longa (turmeric root extract), vitamin b, Echinacea C complete, amlodipine, vitamin c [ascorbic acid], atorvastatin, biotin, carvedilol, cefdinir, vitamin d3, vaccinium macrocarpon (cranberry extract), docosahexaenoic acid, fish oil, green tea extract, probiotic. Prior to the vaccination the patient was not diagnosed with COVID-19. On 25Feb2021, the patient experienced redness, itching, warm to touch at injection site, about the size of a dollar bill. The adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment. Since the vaccination the patient had not been tested for COVID-19. The outcome of the events was recovering.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
she has a lot of pain in the body; Tenderness; Stiffness; Dizzy; she can't lay her arms/can't raise it over her head; she can't lay her arms/can't raise it over her head; she has the soreness; she has 'shaken right her arm, head; she has 'shaken right her arm, head; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP), Program ID: The reporter is the patient.  A female patient received BNT162b2 (BNT162B2), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer), for COVID-19 Immunization.  The following information was reported: PAIN (non-serious), outcome "not recovered", described as "she has a lot of pain in the body"; TENDERNESS (non-serious), outcome "unknown"; MUSCULOSKELETAL STIFFNESS (non-serious), outcome "unknown", described as "Stiffness"; DIZZINESS (non-serious), outcome "unknown", described as "Dizzy"; MOVEMENT DISORDER (non-serious), LIMB INJURY (non-serious), outcome "unknown" and all described as "she can't lay her arms/can't raise it over her head"; PAIN (non-serious), outcome "unknown", described as "she has the soreness"; TREMOR (non-serious), TREMOR (non-serious), outcome "unknown" and all described as "she has 'shaken right her arm, head".  Additional Information: Transferring agent stated, "I have a caller on the other line and the concern of the caller is, she reported this after of the booster shot. She has a lot of pain in the body after 6 months of receiving booster dose of the COVID. Until now she has the soreness and she has 'shaken right her arm, head (Not clear)' and tenderness and the stiffness and being dizzy so a lot of adverse events. she can't lay her arms/can't raise it over her head. The adverse event after taking the injection and it's been 6 months but she hasn't gotten any better 'still the same she can't lay her arms can't raise it over her head.  QR Comment: Reporter type could not be probed hence captured by default as Consumer or other non-health professional in tab. Call got disconnected during the warm transfer. Call back was done however not successful. Hence limited information was available over the call.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Nausea within 1 hour, headache next day, fatigue next day, sore arm for 1 full week
I received my Covid -19 vaccine on 10/21/2022. On 12/26/2022 I started feeling drainage down my throat.  I woke up the next day with body aches and chills. I tested positive that day for Covid -19. After contacting my doctor, I took over the counter medications. Symptoms lasted about a week.
Narrative: Patient experienced nausea following  receipt of his 1st COVID-19 vaccine
Large red rash approx. 4in x 3in at injection site 2 weeks post vaccine; rash started within 1 hour of injection and continually got larger as the days progressed
Head ache, sore throat,fever,chills,body aches arthritis cold sweats weakness
GOT UP LIMPING A LITTLE BIT SORE TO THE TOUCH; RIGHT HIP BOTHERING/ SORENESS; LEFT LEG SWELLING,PARTICULARLY AROUND  AND ABOVE THE ANKLE BY 4 INCHES; 3-4 EPISODES OF DIARRHEA PER DAY/ LOOSE STOOL THAT HAS BEEN BOTH LIQUID AND SEMI FORMED/ STOOLS ARE NORMAL COLOR; This spontaneous report received from a patient concerned a 71 year old female. The patient's height, and weight were not reported. The patient's past medical history included leg injury, and darker skin discoloration, and concurrent conditions included asthma allergies, kiwi allergy, and reflux, and other pre-existing medical conditions included the patient was not pregnant at the time of reporting.The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: 2028A21A expiry: UNKNOWN) dose was not reported, administered on 24-MAY-2021 for prophylactic vaccination. Concomitant medications included bismuth subsalicylate. On 27-MAY-2021, the subject experienced 3-4 episodes of diarrhea per day/ loose stool that has been both liquid and semi formed/ stools are normal color. On 29-MAY-2021, the subject experienced left leg swelling, particularly around and above the ankle by 4 inches. On 30-MAY-2021, the subject experienced got up limping a little bit sore to the touch. On 30-MAY-2021, the subject experienced right hip bothering/ soreness. The action taken with covid-19 vaccine was not applicable. The patient had not recovered from left leg swelling,particularly around and above the ankle by 4 inches, right hip bothering/ soreness, and 3-4 episodes of diarrhea per day/ loose stool that has been both liquid and semi formed/ stools are normal color, and the outcome of got up limping a little bit sore to the touch was not reported. This report was non-serious.
Patient was mistakenly given a third dose of moderna vaccine bedside at long term care facility (28 days following the second dose)
A non-serious, spontaneous report of gave FLUMIST to a nine-month-old was received from a health professional concerning an eight-month-old male. Neither medical history nor concomitant medication was reported for this patient. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved. This case will be submitted in accordance with MedImmune's FLUMIST post-marketing commitment for the indicated population of 2 years to 59 months of age.
HANDS NUMBNESS ESPECIALLY FINGERS TIPS; FEELING OFF; BODY TINGLING; JITTERY; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805025, and batch number: 1805025 expiry: UNKNOWN) .5 ml, administered on 09-MAR-2021 11:00 to Left Arm for prophylactic vaccination. No concomitant medications were reported.  On 09-MAR-2021, the subject experienced body tingling. On 09-MAR-2021, the subject experienced jittery. On 09-MAR-2021 17:30, the subject experienced feeling off. On 09-MAR-2021 18:00, the subject experienced hands numbness especially fingers tips. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from hands numbness especially fingers tips, and jittery, and had not recovered from feeling off, and body tingling. This report was non-serious.
Initial unsolicited report received from a healthcare professional on 4 February 2016. This case involves a 61 years old female patient who was vaccinated with a dose of Adacel, (batch number, expiry date, dose and dose number were not reported) via unspecified route in arm and also received Zostavax (Manufacturer: Merck, batch number, expiry date, dose and dose number were not reported) via unspecified route in arm both on an unspecified date (either late September or early October). Patient had medical history of allergies to Sulfa, possibly latex and minor arthritis and concomitant medications were not reported. On an unspecified date one month post vaccination, the patient had blood work done and slight increase in RA factor and experiencing swelling, redness, pain of all fingers of both hands. Patient also stated that he had appointment with rheumatologist but appointment could not be scheduled until March, 2016. It was reported that patient had doctor visit. Lab data and corrective treatments were not reported. At the time of this report, the outcomes of the events were not recovered. List of documents held by sender: none.
This is a spontaneous report from a contactable pharmacist. An 86-year-old female patient of unspecified race/ethnicity received PREVNAR 13, via an unspecified route of administration, on 17May2017, at single dose, for immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced redness and swelling at the injection site on an unspecified date with outcome of unknown. No follow-up attempts possible. No further information expected.
fever, swelling & redness around shot site; DPH-amoxicillin; In 1990 reaction to DT, redness & swelling @ shot site then becamse abscessed;
On Saturday my daughter felt like she was going to pass out in a couple of instances, I checked her vitals and BP and Oxygen were normal, but her heart rate was 145. Her heart fluctuated between 145 and a130 all day and was irregular. On Sunday, her heart rated did slow down, but still at about 110- 130's and was still irregular.  Her heart normalized by Monday.
Heart palpitations, chest pain, shortness of breath, very high heart rate. Went to hospital and was admitted in immediately. Can last up to 3 days after each episode. Treatment from hospital was beta blocker. Diagnosis was anxiety which lead to hydroxyzine medication.  But ended up the hospital again for very high heart rate again. Still having heart problems , chest pains and shortness of breath
Patient had a syncopal episode in the passageway outside of treatment room about 1-2 minutes after receiving vaccinations. Patient was helped to the ground by mother of patient who shouted for a corpsman. Corpsman was unable to rouse patient by tapping/shaking shoulders but patient was aroused after he performed a sternal rub. Patient was unresponsive for approximately 10 seconds. Patient's BP was taken on scene and reported as 78/50 and heart rate was 60. Code was called and patient was escorted to emergency room.
Information has been received from a licensed practical nurse concerning her 6 year old daughter who in 10/96 was vaccinated with a dose of Varivax.  On 02/02/02, the pt developed chicken pox with about 40 lesions. There were no other symptoms. The patient sought unspecified medical attention. FOLLOW-UP information reported no other adverse events. It was noted there had been several cases of "questionable chicken pox," in the patient's class, and the reporter was interested in determining if this was actually varicella. No further informatioin is available.
9 days post vax, the pt developed hives, which extended from the trunk to legs. He was treated with Benadryl which initially resolved the hives; however, they returned by morning.
Severe stomach pains for 5 days, they have continued; Severe sore throat for 5+ days; loss of appetite for 5+ days
Patient received only the liquid portion of the PENTACEL vaccine. The powder portion (Hib) was not given. Age of patient at time of event: 4 months.
FLU AND PNEUMONIA ADMIN IN R ARM @ PT'S REQUEST.  SAW PMD ON 10/24/2005 WITH RED STREAKS GOING DOWN ARM BACK TO ELBOW.  A PMD TREATED WITH ANTIBIOTICS
Major localized swelling at injection site, right upper arm, near the shoulder, eight days after receiving the vaccine. Swelling, bruising, and red inflammation at and around injection site. Arm/Shoulder is warm to the touch.
Red blisters appearing on back, abd, legs, hairline with itching. No fever or pain. Dr.  ordered prednisone to treat and benedryl.
arm soreness; tiredness; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 74 year-old female patient received bnt162b2 (BNT162B2), administration date 26Aug2021 (Batch/Lot number: unknown) at the age of 74 years as dose 3 (booster), single, administration date 20Feb2021 (Lot number: EL8982) as dose 2, single and administration date 30Jan2021 (Lot number: EN5318) as dose 1, single for covid-19 immunisation. Relevant medical history included: "immunocompromised" (unspecified if ongoing); "cancer survivor" (ongoing); "COPD" (ongoing); "afib" (ongoing). The patient took concomitant medications. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "arm soreness"; FATIGUE (non-serious), outcome "unknown", described as "tiredness".  Additional information: Just a little arm soreness and tiredness. The extreme tiredness where they were in bed for 3-4 days and the fever they did not have before (with previous shots).   The lot number for bnt162b2 was not provided and will be requested during follow up.
Development of Parkinsonism, ongoing follow-up to determine if PD or atypical Parkinsonism
After administration of the first dose of the  COVID19 vaccine (Pfizer) intramuscularly to the left deltoid, the patient experienced right hand tingling.  Patient was monitored for 30 minutes, at which point symptoms had resolved.    This patient received his second dose of vaccine (from same lot # EH9899) on 1-6-20201 and no adverse reactions were displayed.
Patient said 3 days after she received the vaccine she broke out with herpies.  She does have history, but it only occurs once or twice a year.  She treated with acyclovir and it resolved.  Then on 10/25 she had an outbreak of shingles.  She was previously vaccinated for shingles
Smallpox vaccine 09/19/03.  On 09/26/03, erythematous rash with excessive drainage from SP site.  Primary response, malaise, fatigue, axillary and groin lymph. Prescribed Tequin for 5 days, developed mutiple erythematous pustular lesion back, chest.  Re-evaluated 10/06/03, pustular lesions scabbed, erythematous lesions.
Persistent cough; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Persistent cough) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Knee surgery NOS on 01-Feb-2021.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced COUGH (Persistent cough). The patient was treated with STEROIDS (oral) for Cough, at an unspecified dose and frequency. At the time of the report, COUGH (Persistent cough) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, SARS-CoV-2 test: NEGATIVE.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
No adverse effects reported; Multiple patients were vaccinated with improperly stored ROTATEQ on multiple dates; Information has been received from a medical assistant concerning a patient of unknown age, gender and race. The patient's medical history, drug allergies, previously drug reactions, concurrent conditions and concomitant medications were not reported.  On 14-NOV-2018, the patient was vaccinated with an improperly stored dose of Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) orally for prophylaxis (lot number R005865 with expiration date in 22-OCT-2019) (strength and anatomical location were not provided).  The Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) was stored at an unknown temperature for an unknown time frame. There was a previous temperature excursion and the call was because of a data logger.  No adverse effects reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1907USA001849: US-009507513-1907USA001848: US-009507513-1906USA011434: US-009507513-1907USA001793: US-009507513-1907USA001794: US-009507513-1907USA001795: US-009507513-1907USA001796: US-009507513-1907USA001797: US-009507513-1907USA001798: US-009507513-1907USA001799: US-009507513-1907USA001800: US-009507513-1907USA001801: US-009507513-1907USA001802: US-009507513-1907USA001803: US-009507513-1907USA001804: US-009507513-1907USA001805: US-009507513-1907USA001806: US-009507513-1907USA001807: US-009507513-1907USA001808: US-009507513-1907USA001809: US-009507513-1907USA001810: US-009507513-1907USA001812: US-009507513-1907USA001813: US-009507513-1907USA001814: US-009507513-1907USA001815: US-009507513-1907USA001816: US-009507513-1907USA001817: US-009507513-1907USA001818: US-009507513-1907USA001819: US-009507513-1907USA001820: US-009507513-1907USA001821: US-009507513-1907USA001822: US-009507513-1907USA001823: US-009507513-1907USA001824: US-009507513-1907USA001825: US-009507513-1907USA001826: US-009507513-1907USA001827: US-009507513-1907USA001828: US-009507513-1907USA001829: US-009507513-1907USA001830: US-009507513-1907USA001831: US-009507513-1907USA001832: US-009507513-1907USA001833: US-009507513-1907USA001834: US-009507513-1907USA001835: US-009507513-1907USA001836: US-009507513-1907USA001837: US-009507513-1907USA001838: US-009507513-1907USA001839: US-009507513-1907USA001840: US-009507513-1907USA001841: US-009507513-1907USA001842: US-009507513-1907USA001843: US-009507513-1907USA001844: US-009507513-1907USA001845: US-009507513-1907USA001846: US-009507513-1907USA001847: US-009507513-1907USA000952: US-009507513-1907USA000953: US-009507513-1907USA000954: US-009507513-1907USA000959: US-009507513-1907USA000962: US-009507513-1907USA000963: US-009507513-1907USA000964: US-009507513-1907USA000965: US-009507513-1907USA000966: US-009507513-1907USA000967: US-009507513-1907USA000968: US-009507513-1907USA000969: US-009507513-1907USA000970: US-009507513-1907USA000988: US-009507513-1907USA000989:
Patient received the vaccine in the left deltoid at 11:22:23 am and she said it didn't hurt and she seemed totally fine.  She stood up and was talking as I gave her brother his vaccine and she was watching him get his shot and she just suddenly fell forward.  She fainted and fell towards her father.  We laid her on the floor and she was very rigid with twitching like behavior.  I asked the father if she had any reaction like this to a vaccine or and history of seizure and he said no.  I am not sure how long she was unresponsive-perhaps a minute.  When she began to wake up she didn't remember falling, but said that as she watched her brother get his shot everything got blurry.  Her eyes were very dilated.  The patient also threw up once she was awake and sitting in a chair.  EMS was called and the family refused transport via ambulance but they went to the emergency room afterwards.
Noticed redness and swelling, felt hard and hot to touch. Starting on 3/12/03 at 13:00. Tylenol given for pain.
Day 9 after vaccine - local itching, erythematous hot ~9x6 cm area at site on  L arm. Fading after 3 days.
she became, dizzy, weak, nauseous, sleet long, long hours and is still sleepy. had  and has a itchy rsh about the size of a playing around injection site. A sore arm. She is feeling better now.
,TIRED,HEADACHE,CHILLS,,NAUSIA,FEELING BAD,AND DIARREA.